FROM THE FOUNDATION - Amazon S3...Unrestricted Net Assets Beginning of Year 28,196,097 Restricted...
Transcript of FROM THE FOUNDATION - Amazon S3...Unrestricted Net Assets Beginning of Year 28,196,097 Restricted...
FROM THE FOUNDATIONBritish philosopher and writer Bertrand Russell said, “To conquer fear is the beginning of wisdom.” But how do we conquer something as challenging as cancer? At the Conquer Cancer Foundation (CCF) of the American Society of Clinical Oncology (ASCO), we believe the best way to remove the worries of treating and surviving disease is by outsmarting it. With your support, we are doing this by investing in the brightest minds in cancer research. When it comes to conquering cancer, we must salute and honor the Conqueror in All of Us, including:
• Patients and families who receive cancer diagnoses to find they must rallyagainst this disease;
• Researchers who surmount scientific challenges to identify new discoveries;
• Physicians who advance new treatments and share data to help others; and
• Donors who fund the work that fuels additional innovation and tangible results.
Sometimes, these roles overlap in unimaginable ways. In this year’s annual report, we introduce you to Dr. Dustin Deming, a colorectal cancer researcherdiagnosed with the exact disease he studies only one year after receiving a CCF Young Investigator Award (YIA). Among other factors, he found greater wisdom and empathy from his aggregated role of investigator, doctor, and patient.
In 2016, CCF can point to distinct achievements that helped us fulfill our mission to conquer cancer worldwide by funding breakthrough research and sharing cutting-edge knowledge. First, through your generous financial support, we awarded 339 grants and awards to researchers and research institutions to advance cancer discoveries around the world.
Additionally, 2016 marked continued support of CancerLinQ®, ASCO’s health infor-mation technology platform and Cancer.Net, ASCO’s patient information site, which brings the expertise and resources of ASCO to patients and caregivers everywhere.
We are proud to note that in 2016 CCF maintained a four-star rating –the highest available – from Charity Navigator, the nation’s largest independent evaluator of non-profit organizations. Our four-star rating communicates to current and prospective donors that we are using your funds to achieve our goals effectively, efficiently, and ethically. Likewise, CCF received the highly coveted accredited charity designation from Give.Org Charity Review, produced by the BBB Wise Giving Alliance.
Returning to Bertrand Russell, his use of the word Conquer in the context of overcoming fear continues to resonate. As a pacifist, he was not invoking a military battle but instead an inner strength built on knowledge, confidence and hope. We thank you, our dedicated donors and supporters, for helping usincrease knowledge, raise confidence, and instill hope that moves us closer to a world free from the fear of cancer. As we conquer cancer, your continued generosity is everything and we thank you for it.
Sincerely, Thomas G. Roberts, Jr., MD chair
Clifford A. Hudis, MD, FACP, FASCO chief executive officer
Nancy R. Daly, MS, MPH executive vice president & chief philanthropic officer
2016 BOARD OF DIRECTORSThomas G. Roberts, Jr., MD chair
Clifford Hudis, MD, FACP, FASCOceo, ex-officio
Allen Lichter, MD, FASCO ceo, ex-officio (october 8, 2006–june 30, 2016)
Sandra M. Swain, MD, FACP, FASCOtreasurer
Claire A. Huangsecretary
Daniel F. Hayes, MD, FACP, FASCOasco president, ex-officio (june 6, 2016–june 5, 2017)
Julie Vose, MD, MBA, FASCO asco president, ex-officio (june 1, 2015–june 6, 2016)
Nancy R. Daly, MS, MPH executive vice president andchief philanthropic officer, ex-officio
Alexander W. CasdinLawrence H. Einhorn, MD, FASCOJohn H. Glick, MD, FASCO, MACPMichael Gordon, JDGabriel N. Hortobagyi, MD, FACP, FASCORaj Mantena RPhThomas A. Marsland, MD, FASCORobert J. Mayer, MD, FASCOW. Charles Penley, MD, FASCOchair emeritus
Steven T. Rosen, MD, FACPAaron A. SassonMargaret A. Tempero, MD, FASCO
FINANCIAL REVIEWYou contributed more than $23M to fund breakthrough research and share cutting-edge knowledge.
REVENUESCorporate 12,852,081
Foundation 8,393,684
Individual 1,913,078
TOTAL REVENUES 23,158,843
EXPENSESPrograms 22,485,135
Fundraising 4,314,097
Administration 291,843
TOTAL EXPENSES 27,091,075
Operating Deficit –3,932,232
Long Term Investment 1,559,868
Change in Net Assets –2,372,364
> Change in Unrestricted Net Assets 2,141,362
> Change in Restricted Net Assets –4,513,726
Unrestricted Net Assets Beginning of Year 28,196,097
Restricted Net Assets Beginning of Year 29,695,728
Unrestricted Net Assets End of Year 30,337,459
Restricted Net Assets End of Year 25,182,002
VALIDATING EFFICIENCY
In 2016, The Conquer Cancer Foundation pursued third-party reviews relative to the stewardship of your vital donations via Give.Org, the Better Business Bureau’s Wise Giving Alliance, and Charity Navigator, the nation’s largest independent evaluator of non-profit organizations. Using more than 20 different metrics, both groups assess and confirm qualities such as fair governance, positive program results, financial accountability and overall transparency. These examinations communicate to current and prospective donors that we are using your generous donations to achieve our goals effectively, efficiently, and ethically.
Charity Navigator: 4 out of 4 starsGive.Org (BBB): Fully-Accredited
4-S
TAR
RA
TIN
G IN
20
16 O
N C
HA
RIT
Y N
AV
IGA
TO
R
TH
E C
ON
QU
ER
OR
IN
AL
L O
F U
S
On a very unlucky Friday the 13th in July 2012, Dr. Dustin Deming, working in the dual role of gastrointestinal oncology researcher and physician, suddenly took on a third one: patient. Diagnostic irony rang out when he learned it was colorectal cancer. The news came just one year after he received a Conquer Cancer Foundation (CCF) of ASCO Young Investigator Award (YIA) to study the disease.
As researcher, Dr. Deming develops mouse models that reflect the tumor biology of current patients, facilitating rapid treatment protocols. As patient, he hopes to remain free of disease to and beyond the five year mark. As physician, relationships with patients now involve a deeper dimension than before his diagnosis.
Dr. Deming’s treatment for stage 3c colorectal cancer included a cycle of chemotherapy, radiation, surgery, and more chemo. Throughout the process, he continued to work in the lab and to see his patients.
“At some point, it made sense to share my experience. It has yielded huge rewards, professionally and personally,” Dr. Deming added. “One day, a
patient inquired about the mechanics of a chest port. Something clicked, and I just pulled my lab coat and shirt aside and said, ‘This is what it looks like. This is what it feels like. And this is how I feel about it. The physician-patient relationship is forever changed in that moment.”
Still, the fluid nature of Dr. Deming’s three roles has boundaries.
Dr. Deming notes, “when I’m giving a lecture, it’s about the science, not about me. But it really comes back to my desire to feel normal. A diagnosis can be a label that’s impossible to shake.”
Research labs are filled with labels. A single mark defines the spot where a clinical trial moves forward versus one that ends for inefficacy or lack of funding. For Dr. Deming, either result creates urgency.
“I see patients with a specific tumor biology and return to the lab to develop treatment protocols with drug combinations we can use quickly. I value passionate researchers who focus on a specific path for decades, no matter how many times they hit
a wall. Their persistence yields brilliance. By contrast, if something in my lab can’t progress to a clinical trial, we move on to something that can. As a patient – and through my relationship with patients – I seethe need for better treatments daily and I’m compelled to act.”
As a donor, you are also compelled to act. Your generosity absorbs the weight of diagnosis for patients, enhances the quality of care physicians can provide, and enables the brightest minds in cancer research to stay in their labs exploring new ways to improve treatments for all types of cancers.
The Conquer Cancer Foundation is grateful for the generous donors that help fund breakthrough research like Dr. Deming’s, whose early work revealed a new subtype of colon cancer. Your dollars accelerate our ability to share cutting-edge knowledge globally, resulting in new, life-changing discoveries and treatments to conquer cancer and to improve quality of care. Dr. Deming is a conqueror.
And, there is a conqueror in you.
THE CONQUEROR IN DR. DUSTIN DEMING
CO
NQ
UE
R.O
RG
THANK YOU
The Conquer Cancer Foundation of ASCO salutes
the generous involvement of donors whose increased
financial support enabled the significant progress
made this year.
Whether donor, researcher, physician, patient, or some
combination of these roles, mobilizing the Conqueror in
All of Us through teamwork and professional development
remains the best way to advance breakthrough research
and improved care. Nearly 1.8 million people in the US
were diagnosed with cancer in 2016 and, internationally,
19.5 million cases will be identified annually by 2025.
Sources:
(1) https://www.cancer.gov/about-cancer/understanding/statistics
(2) https://www.cdc.gov/cancer/international/statistics.htm
ADVANCING RESEARCH
At CCF’s core is the desire to forward research initiatives that originate from the brightest minds in cancer research. Your generous contributions in 2016 allowed investigators around the world to study subjects as diverse as:• Assessing treatment preferences and goals for older
adults with cancer;• Preventing, detecting and treating a rare form of
bile duct cancer;• Examining melanoma cell mutation resistance; and• Developing new immunotherapies for leukemia.
The Campaign to Conquer Cancer
May 2015 LaunchDecember 2016$139M Goal$150M
Grants & Awards
339 Total
Young Investigator Awards (YIA)
58 Total
BUILDING ON KNOWLEDGE
For Professionals — Amidst record-setting attendance, ASCO’s Annual Meeting welcomed former Vice President Joe Biden who urged conference-goers to provide bold ideas to advance the nation’s Cancer Moonshot Initiative.
An additional five symposia throughout 2016 offered interactive educational opportunities for more than 8,000 participants dedicated to cancer survivorship, quality and palliative care, and genitourinary and gastrointestinal cancers.
For Patients and Families — With the launch of an accessibility initiative to increase functionality for people with disabilities, Cancer.Net continued to provide valuable, vetted, and up-to-date cancer information. Your philanthropic gifts resulted in a banner year for Cancer.Net: the information ecosystem received 11 awards for its overall utility, blog, podcasts and mobile app, including a Gold Award for Best Healthcare Content from the eHealthcare Leadership Awards.
Patient Records
1M+ → 1.5M+Oncology Practices
20 → 78(+190%)
Annual MeetingAttendance
28K → 32K
From
(2015 → 2016)
Cancer.Net Site Traffic
25% →
CHAMPIONING DISCOVERY: BIG DATA
For Physicians and Researchers —
With thoughtful donor support, CCF continues
to build and to promote CancerLinQ®, a real-time
electronic health records platform whose data
provides physicians with immediate insights
about effective treatment protocols
and patient care.
Conquer Cancer Foundation
@ConquerCancerFD
conquercancerfoundation
FUNDING WOMEN IN SCIENCE
Women Who Conquer Cancer (WWCC) promotes female leadership in oncology research and assists early-career women physicians transitioning from their final years of training into new faculty appointments. Your financial gifts enabled women-led networking and career support initiatives throughout 2016.
Celebrating Female MentorshipSarah S. Donaldson, MD, FASCO received the inaugural WWCC Mentorship Award in 2016. As the first female president of multiple national medical societies and a leading pediatric oncology researcher and patient care advocate, colleagues cite Dr. Donaldson’s defining career achievement as her steadfast mentorship.
Continue efforts to raise
$1.35M toward endowing a WWCC Young Investigator Award
WWWC Young Investigator Awards
1 → 3recipients
IDEA Nations
17
International Development and Education Award (IDEA)IDEA Awards
23
Long-term International Fellowship (LIFe)
Awards
4 Nations:Mexico, Brazil, China and Jordan
Countries Represented at ASCO Annual Meeting
125 → 149
GLOBAL ONCOLOGY
To fulfill the reach of its mission to conquer cancer
worldwide, CCF invests in grants dedicated to research
around the globe and patients in low and middle-income
countries.
International Guests – 55% of total Cancer.Net traffic
CHAMPIONS Champions are donors who have given $1,000,000 or more cumulatively in their lifetime. Anonymous
American Society of Clinical Oncology
Amgen
Astellas
AstraZeneca
Avon Foundation for Women
Bayer HealthCare Pharmaceuticals Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Breast Cancer Research Foundation®
Bristol-Myers Squibb
Cancer Treatment Centers of America®
Celgene Corporation
Dendreon Corporation
Eisai Inc.
EMD Serono Inc.
Genentech BioOncology™
GlaxoSmithKline Oncology
Gordon Family Foundation
HELSINN
Incyte Corporation
Integra Connect
Janssen Oncology
Lilly
LIVESTRONG Foundation
Raj Mantena, RPh
Merck & Co., Inc.
Novartis Oncology
Pfizer Oncology
Physicians Education Resource
Roche
Sanofi Genzyme
Sarcoma Foundation of America
Aaron and Barbro Sasson
Susan G. Komen®
Takeda Oncology
Teva Oncology
S U P P O R T E R AC K N OW L E D G M E N TThe Conquer Cancer Foundation gratefully acknowledges the individuals and organizations whose
2016 donations are funding breakthrough cancer research and sharing cutting-edge knowledge through The Campaign to Conquer Cancer. Visit CONQUER.ORG to make your 2017 gift.
T H E C O N Q U E R O R I N A L L O F U S
The Conquer Cancer Foundation gratefully recognizes members of the Conquerors Circle who made gifts of $1,000 or more in 2016. Anonymous
Farrukh M. Adhami, MD
Alex A. Adjei, MD, PhD
David Adler
Cathleen Ahearn
Paul Aines
Christina M. Annunziata, MD, PhD
Carol Appel
Jeff and Rebecca Atkinson
Kara Bachman
Joseph S. Bailes, MD, and Yvonne S. Bailes
Ed Balaban
Charles M. Balch, MD, FACS, FASCO, and Carol Balch
Lodovico Balducci, MD
Tarit Kumar Banerjee, MD
Adrian Barfield
Brigitte Barrette, MD
Teresa Bartels
Robert C. Bast, MD, and Blanche S. Bast
Rosemarie Bastone
Susan E. Bates, MD
Tanios S. Bekaii-Saab, MD, FACP
Diana Benson
Monica M. Bertagnolli, MD, and Alexander H. Dannenberg, PhD
Smita and Ravi Bhatia
Nirmala Bhoopalam, MD
Charles D. Blanke, MD, FASCO
Dr. and Mrs. Douglas W. Blayney
Clara D. Bloomfield, MD, FASCO
George J. Bosl, MD, FASCO
Dr. Linda D. Bosserman and Hon. Theodore Piatt
Riccardo Braglia
Hon. Nancy G. Brinker
Susan Brousseau
Paul A. Bunn, Jr., MD, FASCO
Howard A. Burris, III, MD, and Karen Y. Burris
Dr. David Bush
Nicola Bush
Pablo J. Cagnoni, MD
Alejandro R. Calvo, MD
Ila Campbell
Ana Canal and Emilio Canal, Jr., DDS
Michael and Kathy Carducci
Alexander and Susan Casdin
Robert and Katherine Ceremsak
Kuo Chao
Dr. Anita Chawla
Kwai Chow
Neal Paul Christiansen, MD, FACP
Erik Chu
Marc L. Citron, MD
Susan Clare
Glenda Claremon
Bayard Clarkson, MD, BSN, OCN, FASCO
Gary I. Cohen, MD, FASCO, and Charlene M. Cohen
Harvey J. Cohen, MD, and Mrs. Sandra L. Cohen
Susan Lerner Cohn, MD
Terry Coleman
Charles L. Conlon, MD
Lisa Conte
Bob Cox
John V. Cox
Walter J. Curran, Jr., MD, FACR
Violante E. Currie, MD
Anthony Cutrone
Nancy R. Daly, MS, MPH
Chau T. Dang, MD
Nancy E. Davidson, MD, FASCO
Peter Davis
Joseph Deegan-Day
Neelima Denduluri, MD
Julie Dexter
Michael Diaz, MD
Adam and Adrien Dickerson
Gary C. Doolittle, MD
Dana L. Dornsife
Carol D. Doyle-Clarke
James Early
Martin J. Edelman, MD
Stephen B. Edge, MD, FASCO
Lawrence H. Einhorn, MD, FASCO, and Claudette Einhorn
Ira and Roni Elegant
David S. Ettinger, MD
Fleur E. Fairman
Caroline Fales
Stuart P. Feldman, MD
Lisa Fichtel, MD
Margaret Fletcher
Thomas Folchi
James M. Ford, MD
Jill M. Forrest
Dr. Paula M. Fracasso and Mr. John S. Francis
Dr. James and Leslie Frame
Loraine and Bert Fulmer
Gwen A. Fyfe, MD
Patricia A. Ganz, MD, FASCO
Maria Garcia, MD
Elaina M. Gartner, MD
Alfred R. Gaudelli
John A. Gentile, Jr., BSc, RPh
Thomas J. George, Jr., MD, FACP
Phyllis Ghio
Timothy D. Gilligan, MD, MSc
Julia Lynne Glade Bender, MD
John H. Glick, MD, FASCO
Jose Luis Gonzalez
Bobby L. Graham, MD
Bart and Alice Grantham
Bradley Grantham
Sybil R. Green, JD, MHA, RPh
Jean L. Grem, MD
Stephen S. Grubbs, MD
Dr. Missak Haigentz and Mrs. Madaline Haigentz
Roger Halualani
John and Jessie Hart
Cheryl A. Harth, MD
Lawrence Haskell
Daniel and Jane Hayes
Charles A. Henderson, MD
Carolyn B. Hendricks, MD
Betty Hinds
Adam and Denise Hoeflich
Paulo M. Hoff, MD, FACP
Sandra J. Horning, MD
Bob and Jeanne Hsia
Claire Huang and Mark Wildermuth
Clifford A. Hudis, MD
Melissa M. Hudson, MD, and Albert E. Weeks, MD
Erin Hultman
Melinda and James Hurley
Arti Hurria, MD
Maha Hussain, MD, FASCO
Sarah G. Hymowitz, PhD
Lowell F. Inhorn, MD, and Cynthia Petzold
Yassamin and Farid Jalinous
Linda Jensen
Bruce E. Johnson, MD, and Georgia Johnson
Deborah Y. Kamin, PhD
Beth Y. Karlan, MD
Nina J. Karlin, MD, FACP
Suresh B. Katakkar, MD
Jeffrey and Marnie Kaufman
Alan M. Keller, MD
Michael J. Kelley, MD
Jack Kennedy
Edward S. Kim, MD
Jeffrey J. Kirshner, MD
Kimberley Klingler
Feng Ming Kong, MD
Michael P. Kosty, MD, FACP, FASCO
Miodrag Kukrika, MD
Kathleen Lada
Esther Lam
Josh David Lauring, MD, PhD
Ronald L. Lay
Matt Lee
William T. Leslie, MD
Barbara and John Lewis
Michael Paul Link, MD, FASCO
John Lombardi
Phil and Kathey Longorio
Katherine Y. Look, MD
Jennifer A. Low, MD, PhD
Karen H. Lu, MD
Christine Luckscheiter
Drs. Gary H. Lyman and Nicole M. Kuderer
Conor Lynch
Ronald John Maggiore, MD
Phillip Manning
Raj Mantena, RPh
Benjamin T. Marchello, MD, and Mary Lou Marchello
David A. Margileth, MD
Kim Allyson Margolin, MD
Musa and Thomas Mayer
Robert J. Mayer, MD, FASCO
Jodi McDermott
William P. McGuire, MD
David R. Melin
Honor Mello
Robert G. Mennel, MD, FASCO
Drs. Sharon and Neal Meropol
Dina L. Michels, Esq., and Peter Engel
Ryan A. Milburn
Robert S. Miller, MD, FACP, FASCO, and Dorothy Miller
I. Monica Minkoff, MD, and Harry Siegfried
MJ Moltenbrey
Victoria Montgomery
Anne Moore, MD
Robert Morgan, MD
Joanne E. Mortimer, MD
Julie Mosley
Therese M. Mulvey, MD, FASCO
Hyman and Loretta Muss Family Fund
Craig R. Nichols, MD
NF Nimeh, MD
Oleg Nodelman
Dr. Luke and Rachel Nordquist
Susan M. O’Brien, MD
Kevin and Lori O’Connor
Faith D. Ottery, MD, PhD
Ann Paradise
Nayan G. Parekh, PhD
Susan Parsons, MD, and Walter G. Armstrong
Debra Patt MD, Texas Oncology
W. Charles Penley, MD, FASCO, and Connally Penley
Francine Pepitone
Richard Petit
Jennifer Perry, PharmD
Lori J. Pierce, MD, FASCO
Phyllis Pohl
Joseph D. Purvis, MD
Derek Raghavan, MD, PhD, FACP, FASCO
Susan and Kanti Rai
Kimryn Rathmell, MD, PhD
Deana and James Ratto
Pamela and Charles Reardon
M. Michele Redden-Borowski, MD
Robert M. Rifkin, MD
Thomas G. Roberts, Jr., MD, and Susan M. DaSilva
Anne Marie Robertson
Gabrielle Rocque
Gladys I. Rodriguez, MD
Lisa Rodriguez
Angel M. Roman-Diaz, MD
Steven T. Rosen, MD, FACP, and Candice Rosen
Mace and Joyce Rothenberg
Melanie Royce, MD, PhD
Debasish and Suraja Roychowdhury
Carolyn D. Runowicz
Roger and Vicki Sant
Aaron and Barbro Sasson
Richard L. Schilsky, MD, and Cynthia S. Schilsky
Lynn Mara Schuchter, MD, FASCO
Scott Schuetze, MD, PhD
Steven and Gail Shak
Sandra Shaw
Steven Sheck
Frances A. Shepherd, MD
Stephen A. Sherwin, MD
Rachna T. Shroff, MD
Robert D. Siegel, MD
William M. Sikov, MD, FACP
Mr. Jackson G. Simpson
David C. Smith, MD
Eileen P. Smith, MD
Michael L. Smith
David R. Spriggs, MD
Robert J. Stagg, PharmD
Jed Steele
Cora N. Sternberg, MD
James A. Stewart, MD
Mary L. Stewart, MD
Anna M. Storniolo, MD
Joseph Sum
Bob and Bobbie Sutton
Sandra M. Swain, MD, FACP, FASCO, and Steven Jones
Riaz Taplin
Richard Tempero, MD, and Margaret A. Tempero, MD
Marilou Terpenning, MD, FACP
Michael A. Thompson, MD, PhD, and Kelly M. Thompson
Lisa W. Tichenor
Shawn C. Tomasello
Elaine L. Towle
Michael B. Troner, MD, FASCO
Donald L. Trump, MD
William Tunno
Marianne A. Urry
Deanna van Gestel
Daniel and Ann Von Hoff
Jamie H. Von Roenn, MD, FASCO
Julie M. Vose, MD, MBA, FASCO
James L. Wade, MD, FASCO
Olivia Ware
David M. Waterhouse, MD, MPH
Kenneth and Andrea Weckstein
Mike White
Pamela Wilder
Eric P. Winer, MD, FASCO
Janice Wise
Jedd D. Wolchok, MD, PhD
Robert A. Wolff, MD
Sandra L. Wong, MD, MS
Yu-Ning Wong, MD
Antoinette J. Wozniak, MD
Mr. and Mrs. Robert S. Wu
Christopher Wynn
DeeAnn Yabusaki
William S. Yaus
William Yoon, PharmD
Robert C. Young, MD, FASCO
Ruth T. Young, MD, MA, MHA
Peter P. Yu, MD, FASCO
Sharon and Robert Zachte
Sara L. Zaknoen, MD
Marvin Zalesin
Dr. Robin Zon and Family
Alexander Zukiwski, MD
ORGANIZATIONS Anonymous
Abbey of Our Lady of the Holy Trinity
AbbVie, Inc.
ABIM Foundation
Abt SRBI
Academy of Managed Care Pharmacy
Accurate Development, Inc
Acuity Charitable Foundation, Inc.
Adenoid Cystic Carcinoma Research Foundation
Alabama Cancer Congress
AlphaMed Press
Amazon Smile Foundation
Ambry Genetics
American Cancer Society
American Endowment Foundation
American Legion Riders
American Society for Radiation Oncology
American Society of Clinical Oncology
Amgen
AMN Healthcare
ARIAD Pharmaceuticals, Inc.
The Arizona Clinical Oncology Society
Arthur E. McAlarney Trust
Ascend Federal Credit Union
Assabet Valley Federation of Teachers
Association of Northern California Oncologists
Astellas
AstraZeneca
AstraZeneca Healthcare Foundation
Bank of America Charitable Gift Fund
Barbara Eads Realty, Inc.
Baxalta Matching Gifts Program
Baxalta Incorporated
Bayer HealthCare Pharmaceuticals Inc.
BCCNS Life Support Network
Best Bay Apartments Inc.
Biogen
The Blanke Foundation, Bank of America, N.A., Trustee
Bloomingdale’s
Bluefish Cove Improvement Association
Boehringer Ingelheim Pharmaceuticals, Inc.
Breast Cancer Research Foundation®
Bright Newhouse Insurance
Bristol-Myers Squibb
Bristol-Myers Squibb Foundation
Brooks Brothers
CAE USA, Inc.
Cancer Treatment Centers of America®
Catalina Barber Corporation
Catania, Mahon, Milligram & Rider, PLLC
Celebrant USA Foundation Inc.
Celgene Corporation
Chicago Match Race Center
Cholla Foundation
Clean Solar, Inc.
Coalition of Cancer Cooperative Groups
Coherus BioSciences
Commonwealth of Massachusetts
The Community Foundation for Greater New Haven
Community Foundation of Greater Greensboro
The Community Foundation of Macon County
Cong. of New Square
Connecticut Oncology Association
Covance, Inc.
CRDF Global
CREATION
Crest Flooring
Daniel G. Martinelli Plumbing
Delta Council 44 Air Line Pilots Association
The Donald T. Regan Foundation
East Madison Quilt & Needlework Group
eBay Giving Works
Eisai Inc.
EMD Serono Inc.
Erie Insurance
Ethicon
Evolver, Inc.
Exelixis, Inc.
Ferring Pharmaceuticals,
Inc.
Fidelity Charitable Gift Fund Foundation Medicine Frontier Motel The Fuller Foundation Garcia Family Charitable FoundationGateway for Cancer ResearchGenentech BioOncology™ Genomic Health, Inc. Genpak, LLC Georg Jensen Georgia Society of Clinical Oncology
Gilead Sciences, Inc. Gordon Family Foundation
The Gorelick Family Revocable Trust
GT Management
Guardant Health, Inc.
Harborside Press
Harmelin & Associates, Inc.
Harnish Transportation, Inc.
Hawaii Society of Clinical Oncology
Hedgepeth Williams Middle School of the Arts
HELSINN
Hematology Oncology Managers of New York, Inc.
The Hera Foundation
Hewlett-Packard, Inc.
Hilton Chicago
Hollander Hambleton Family Trust
Hyatt
Hymowitz Family Foundation
Ibabao Realty, LLC
iGive.com
Illinois Medical Oncology Society
Illumina, Inc.
Inc Research, LLC
Incyte Corporation
Indiana Oncology Society
Industrial Aircraft Lodge No. 1746
Infinity Pharmaceuticals Inc.
Insearch Consulting LLC
Integra Connect
Interstate Casing Corporation
Ipsen Biopharmaceuticals Inc.
J. Edward Mahoney Foundation
Janssen Oncology
Japan Comprehensive Cancer Network, Breast
Jazz Pharmaceuticals
JCPenney
Jeanne V. Reed Charitable Foundation
The John and Elizabeth Leonard Family Foundation
Journal of Clinical Oncology
JP Morgan Chase
Foundation
JPS Services LLC/DBA Gem Services
JustGive.org
Kansas Society of Clinical Oncology
Kegonsa Hustlers 4-H Club
Kelly Cares Foundation
Kendra Scott
Kidney Cancer Association
L & M Plumbing and Heating
La Perla
Lawrence J. Epstein Living Trust
Leo H. Bendit Charitable Foundation
Letters & Sciences
Lighthouse Pointe
Lighthouse Sunday School Class
Lilly
Local Independent Charities of America
Lord and Taylor
Ludwig Cancer Research
Lung Cancer Alliance
Macy’s / Bloomingdale’s
The Maggie & Waggie Foundation, a Donor Advised Fund of Renaissance Charitable Foundation
Marchello Family Fund
Martin and Mary L. Boyer Foundation
Maryland/D.C. Society of Clinical Oncology
Massachusetts Medical Society
McGivney Global Advisors LLC.
MCM Education
MD Anderson Cancer Center
Medical Oncology Association of Southern California, Inc.
Medivation
Megabyte Licensing Corporation
The Melior Group, Inc.
Melody & Company, Inc.
Merck & Co., Inc.
Merrimack
Pharmaceuticals
Michael Price and Associates, LLC.
Michael’s Mission
Michiana Hematology Oncology
Michigan Society of Hematology and Oncology
Microsoft
Millennium Pharmaceuticals Matching Gift Program
Minnesota Society of Clinical Oncology
Missouri Oncology Society
Modern Luxury
Montana State Oncology Society
Morgan Stanley Smith Barney Global Impact Funding Trust, Inc
MSA Research, LLC.
Mt. Airy Mattress
My Tribute Gift Foundation, Inc.
Myriad Genetics, Inc.
Nancy Brinker Charitable Foundation
National Alliance of Postal and Federal Employees Local 410
National Cancer Institute
National Christian Foundation®
National Comprehensive Cancer Network
National Data Systems, LLC
Network For Good
Nevada Oncology Society
New Rhein Healthcare, LLC
The New York Community Trust
Nieman Charitable Foundation Inc.
North Carolina Oncology Association
North Coast Driving School
Northern New England Clinical Oncology Society
Northern Trust Charitable Giving Program at the Chicago Community Foundation
Novartis Oncology
Novocure
NY Intl ATC Hockey Team
Oregon Society of Medical Oncology
Parkway Wozniak Memorial Home, Inc.
Patient Access Network Foundation
Patient Alliances
Patient Resource LLC
Patricia Hyde Living Trust
PayPal Gives Employee Engagement Fund
Pennridge Central Middle School Microloans Club
Penske Truck Leasing
The Peter Daniel Seligman Foundation
Pfizer Foundation
Pfizer Oncology
Pharmacyclics LLC
Quantum Group
Raymond James Charitable Endowment Fund
RBR Partnership
Region Welding of Missouri
Renaissance Charitable Foundation, Inc.
Research Advocacy Network
Research To Practice
rEvolution Marketing LLC
The Richardson Family Revocable Living Trust
Roche
Rocky Mountain Oncology Society
Roland-Story High School National Honor Society
The Romano Family Private Foundation
RSG Investment Group, LLC.
Sacro Plaza Reading Room
Schwab Charitable Fund
Seattle Genetics
Senior Citizens Friendship Club
Six Stars Auto Sales, Inc.
Snyder Swimming Pools, Inc.
Sofitel Luxury Hotels
South Bend Medical
Foundation
Southfield Oncology Institute
St. John Knits
Star Nails
Stavros Niarchos Foundation
Steel City Bowling League
Strike 3 Foundation
Substance
Subway
Susan Frankl & George Demetri Charitable Foundation
Susan G. Komen®
TAIHO Oncology, Inc.
Takeda Oncology
Tennessee Oncology Practice Society
TESARO
Texas Society of Clinical Oncology
Thomas S. Brown Associates, Inc.
Tokai Pharmaceuticals, Inc.
Tory Burch
Tri-City Christian School
Trinity Lutheran School
Triple Negative Breast Cancer Foundation
TRUiST
United Way of Central New Mexico
United Way of the Columbia- Willamette
UnitedHealth Group
University of Colorado Health
Utah Hematology Oncology, P.C.
Vanguard Charitable Endowment Program
Virginia Association of Hematologists & Oncologists
W.M. Keck Foundation
Waldorf Astoria Chicago
Washington State Medical Oncology Society
The Waterloo Boys of Southeastern PA
Webster Properties
Wells Fargo Philanthropy Fund
West Virginia Oncology Society
Westerlin Flying Service, Inc.
White & Day Mortuaries
Willing Workers Sunday School Class, Poplar Ridge Christian Church
Wisconsin Association of Hematology and Oncology
The Wrightson Family Endowment Fund
The WWWW Foundation, Inc. (QuadW) and The Sarcoma Fund of the QuadW Foundation of Communities Foundation of Texas
YourCause, LLC Trustee for Chevron Matching Employee Funds
YourCause, LLC Trustee for PepsiCo Employee Giving Program
CANCERLINQ MAJOR SUPPORTERS AmgenAstellasAstraZenecaBayer HealthCare Pharmaceuticals Inc.Boehringer Ingelheim Pharmaceuticals, Inc.Cancer Treatment Centers of America®Chan Soon-Shiong Family FoundationGenentech BioOncology™HELSINNJanssen OncologyLillyRaj Mantena, RPhNovartis OncologyPfizer OncologyThomas G. Roberts, Jr., MD, and Susan M. DaSilvaSusan G. Komen®
MISSION ENDOWMENTFounding DonorsGenentech BioOncology™GlaxoSmithKline OncologyNovartis OncologySanofi Genzyme
Sustaining DonorsAbbVie, Inc.AmgenAstellasAstraZenecaCelgene CorporationEisai Inc.EMD Serono Inc.Gilead Sciences, Inc.HELSINNIncyte CorporationIntegra ConnectLillySanofi GenzymeTakeda Oncology
ENDOWMENTSENDOWED YIAs FOR 2016
JANE C. WRIGHT, MD, ENDOWED YOUNG INVESTIGATOR AWARD
Supporting all areas of cancer research
Srinivas Viswanathan, MD, PhD Will explore the potential to selectively target a novel pathway that degrades prematurely terminated mRNA in certain cancers
Supported By
ANNA BRAGLIA ENDOWED YOUNG INVESTIGATOR AWARD
IN CANCER SUPPORTIVE CARE, SUPPORTED BY HELSINNSupporting cancer supportive care
First YIA recipient to be awarded in 2017.
Supported By
ÅKE BERTIL ERIKSSON ENDOWED YOUNG
INVESTIGATOR AWARDSupporting all areas of cancer research
David Kurtz, MD Will investigate the use of serial circulating tumor DNA measurements to determine response to treatment in diffuse large B-cell lymphoma (DLBCL)
Supported By Aaron and Barbro Sasson
ENDOWMENTSENDOWED YIAs FOR 2016
CONQUER CANCER FOUNDATION OF ASCO YOUNG
INVESTIGATOR AWARD IN MEMORY OF SALLY GORDONSupporting all areas of cancer research
Sarah Derks, MD Will detail the immune suppressant mechanisms in esophageal adenocarcinoma and develop approaches that will allow the immune system to attack these cancers
Supported By Anonymous
CONQUER CANCER FOUNDATION
OF ASCO YOUNG INVESTIGATOR AWARD IN MEMORY OF EVELYN H. LAUDERSupporting breast cancer research
Sangeetha Reddy, MD, MSc Will investigate the role of immune system cells in the tumor on the response to chemotherapy
Supported By
CONQUER CANCER FOUNDATION
OF ASCO YOUNG INVESTIGATOR AWARD IN MEMORY OF JOHN R. DURANT, MDSupporting all areas of cancer research
Scott James, MD, PhD Will develop a new way to make CAR T cell therapy significantly safer by reducing or preventing immune attack against healthy tissues
Supported By
CONQUER CANCER FOUNDATION
OF ASCO YOUNG INVESTIGATOR AWARD IN MEMORY OF SALLY GORDONSupporting all areas of cancer research
2016
Lara AnnDunn, MD Studied a novel targeted drugtherapy to treat metastatic radioiodine-refractory thyroid cancers
Benjamin Lok, MDWill evaluate two new potential predictivebiomarkers for PARP inhibitor sensitivityin Small Cell Lung Carcinoma (SCLC)
Supported ByAnonymous
Benjamin Lok, MD Will evaluate two new potential predictive biomarkers for PARP inhibitor sensitivity in Small Cell Lung Carcinoma (SCLC)
Supported By Anonymous
201620162016